ATE354656T1 - Von menschlichem tumor stammendes polypeptidhormon phosphatonin - Google Patents
Von menschlichem tumor stammendes polypeptidhormon phosphatoninInfo
- Publication number
- ATE354656T1 ATE354656T1 AT99926320T AT99926320T ATE354656T1 AT E354656 T1 ATE354656 T1 AT E354656T1 AT 99926320 T AT99926320 T AT 99926320T AT 99926320 T AT99926320 T AT 99926320T AT E354656 T1 ATE354656 T1 AT E354656T1
- Authority
- AT
- Austria
- Prior art keywords
- human tumor
- derived polypeptide
- polypeptide hormone
- phosphatonin
- human protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810681.8A GB9810681D0 (en) | 1998-05-18 | 1998-05-18 | Hormone |
GBGB9819387.3A GB9819387D0 (en) | 1998-05-18 | 1998-09-04 | Polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE354656T1 true ATE354656T1 (de) | 2007-03-15 |
Family
ID=26313705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99926320T ATE354656T1 (de) | 1998-05-18 | 1999-05-18 | Von menschlichem tumor stammendes polypeptidhormon phosphatonin |
Country Status (13)
Country | Link |
---|---|
US (6) | US6818745B1 (de) |
EP (1) | EP1086225B1 (de) |
JP (1) | JP4424575B2 (de) |
CN (1) | CN100359015C (de) |
AT (1) | ATE354656T1 (de) |
AU (1) | AU765349B2 (de) |
CA (1) | CA2329054C (de) |
DE (1) | DE69935220T2 (de) |
DK (1) | DK1086225T3 (de) |
ES (1) | ES2281964T3 (de) |
MX (1) | MXPA00011272A (de) |
TW (1) | TWI227734B (de) |
WO (1) | WO1999060017A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810681D0 (en) * | 1998-05-18 | 1998-07-15 | Royal Free Hosp School Med | Hormone |
WO1999060017A2 (en) * | 1998-05-18 | 1999-11-25 | University College London | Human tumour-derived polypeptide hormone phosphatonin |
WO2001032878A2 (en) * | 1999-11-04 | 2001-05-10 | University College London | A novel polypeptide hormone phosphatonin |
US6790639B2 (en) * | 2000-02-29 | 2004-09-14 | Pfizer Inc. | Mammalian osteoregulins |
WO2001072826A2 (en) * | 2000-03-24 | 2001-10-04 | Genzyme Corporation | Oncogenic osteomalacia-related gene 1 |
GB0008936D0 (en) * | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Vectors |
US20030175808A1 (en) * | 2000-06-21 | 2003-09-18 | Tomofumi Kurokawa | Novel protein and dna thereof |
DE60142239D1 (de) | 2000-08-11 | 2010-07-08 | Kyowa Hakko Kirin Co Ltd | DEN PHOSPHORSÄURE-METABOLISMUS, DEN KALZIUM-METABOLISMUS, VERKALKUNG UND DEN VITAMIN D-METABOLISMUS KONTROLLIERENDE POLYPEPTIDE SOWIE FüR DIESE KODIERENDE DNA-MOLEKÜLE |
US6911425B2 (en) | 2000-08-16 | 2005-06-28 | Acologix, Inc. | Integrin binding motif containing peptides and methods of treating skeletal diseases |
DK1313440T3 (da) | 2000-08-16 | 2008-11-03 | Acologix Inc | Dentalprodukter indeholdende knoglevækstforögende peptider |
ATE441666T1 (de) | 2001-12-28 | 2009-09-15 | Kyowa Hakko Kirin Co Ltd | Antikírper gegen den fibroblastenwachstumsfaktor 23 |
US7638486B2 (en) | 2005-07-18 | 2009-12-29 | Acologix, Inc. | Method for promoting hard tissue formation |
JP2009511426A (ja) * | 2005-08-30 | 2009-03-19 | アコロジックス インコーポレイティッド | ミネラルおよび骨格代謝の調節 |
WO2007032559A1 (ja) * | 2005-09-15 | 2007-03-22 | Osaka University | 新規モノクローナル抗体及びその用途 |
JPWO2007032560A1 (ja) * | 2005-09-15 | 2009-03-19 | 国立大学法人大阪大学 | 新規モノクローナル抗体及びその用途 |
US7825217B2 (en) * | 2006-09-15 | 2010-11-02 | University Of Kansas Medical Center | Polypeptides for bone mineralization |
MX2009007693A (es) | 2007-01-22 | 2009-08-31 | Acologix Inc | Composicion de peptido y metodo para promover la formacion de cartilago. |
US7883705B2 (en) | 2007-02-14 | 2011-02-08 | Kyowa Hakko Kirin Co., Ltd. | Anti FGF23 antibody and a pharmaceutical composition comprising the same |
AU2010210600B2 (en) | 2009-02-06 | 2016-07-14 | C3 Jian, Inc. | Calcium-binding agents induce hair growth and/or nail growth |
BR112020015291B1 (pt) * | 2018-03-19 | 2023-09-26 | Regeneron Pharmaceuticals, Inc | Tampão de amostra de eletroforese aquoso, método para identificar contaminantes ou impurezas em uma amostra de fármaco proteico, e, kit |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
US5340934A (en) * | 1989-11-03 | 1994-08-23 | The United States Of Americas As Represented By The Secretary Of Health & Human Services | CDNA sequences of human bone matrix proteins |
GB9203958D0 (en) * | 1992-02-25 | 1992-04-08 | Norske Stats Oljeselskap | Catalytic multi-phase reactor |
EP0679716A4 (de) * | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | Genetische Signaturen. |
US5981478A (en) | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
US6103709A (en) * | 1993-12-23 | 2000-08-15 | The Regents Of The University Of California | Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases |
US5770565A (en) * | 1994-04-13 | 1998-06-23 | La Jolla Cancer Research Center | Peptides for reducing or inhibiting bone resorption |
US6027592A (en) * | 1995-06-06 | 2000-02-22 | Gillette Canada Inc. | Dental floss |
US6300062B1 (en) * | 1995-07-13 | 2001-10-09 | Biora Ab | Enamel matrix related polypeptide |
US5837674A (en) * | 1996-07-03 | 1998-11-17 | Big Bear Bio, Inc. | Phosphopeptides and methods of treating bone diseases |
EP1003570A1 (de) | 1997-08-15 | 2000-05-31 | Children's Medical Center Corporation | Osteopontinbeschichtete oberflächen und verfahren zur verwendung |
US6146655A (en) * | 1997-08-29 | 2000-11-14 | Softy-Flex Inc. | Flexible intra-oral bandage and drug delivery system |
US6410248B1 (en) | 1998-01-30 | 2002-06-25 | Massachusetts Institute Of Technology | General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites |
WO1999043844A1 (en) | 1998-02-27 | 1999-09-02 | The Trustees Of Columbia University In The City Of New York | Reciprocal subtraction differential display |
US6673900B2 (en) * | 1999-11-04 | 2004-01-06 | University College London | Polypeptide hormone-phosphatonin |
WO1999060017A2 (en) | 1998-05-18 | 1999-11-25 | University College London | Human tumour-derived polypeptide hormone phosphatonin |
US7098185B2 (en) * | 1998-05-18 | 2006-08-29 | University College London | Polypeptide hormone phosphatonin |
US6045780A (en) * | 1998-06-22 | 2000-04-04 | Shemberg Marketing Corporation | Toothpaste composition |
AUPP893999A0 (en) | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
US6145655A (en) | 1999-10-04 | 2000-11-14 | Tsai; Allan | Lens cleaning kit |
US6790639B2 (en) * | 2000-02-29 | 2004-09-14 | Pfizer Inc. | Mammalian osteoregulins |
WO2001072826A2 (en) | 2000-03-24 | 2001-10-04 | Genzyme Corporation | Oncogenic osteomalacia-related gene 1 |
CN100350971C (zh) | 2000-07-19 | 2007-11-28 | 奥索洛吉艾斯有限公司 | 用凝血酶肽衍生物刺激骨生长 |
US6911425B2 (en) * | 2000-08-16 | 2005-06-28 | Acologix, Inc. | Integrin binding motif containing peptides and methods of treating skeletal diseases |
-
1999
- 1999-05-18 WO PCT/EP1999/003403 patent/WO1999060017A2/en active IP Right Grant
- 1999-05-18 JP JP2000549635A patent/JP4424575B2/ja not_active Expired - Lifetime
- 1999-05-18 DK DK99926320T patent/DK1086225T3/da active
- 1999-05-18 US US09/700,696 patent/US6818745B1/en not_active Expired - Lifetime
- 1999-05-18 DE DE69935220T patent/DE69935220T2/de not_active Expired - Lifetime
- 1999-05-18 EP EP99926320A patent/EP1086225B1/de not_active Expired - Lifetime
- 1999-05-18 MX MXPA00011272A patent/MXPA00011272A/es active IP Right Grant
- 1999-05-18 TW TW088108226A patent/TWI227734B/zh not_active IP Right Cessation
- 1999-05-18 CN CNB998063614A patent/CN100359015C/zh not_active Expired - Lifetime
- 1999-05-18 CA CA2329054A patent/CA2329054C/en not_active Expired - Fee Related
- 1999-05-18 AU AU43624/99A patent/AU765349B2/en not_active Ceased
- 1999-05-18 AT AT99926320T patent/ATE354656T1/de active
- 1999-05-18 ES ES99926320T patent/ES2281964T3/es not_active Expired - Lifetime
-
2004
- 2004-08-17 US US10/920,788 patent/US7271151B2/en not_active Expired - Lifetime
-
2006
- 2006-05-01 US US11/381,094 patent/US20070185010A1/en not_active Abandoned
- 2006-05-03 US US11/381,470 patent/US7655760B2/en not_active Expired - Fee Related
-
2007
- 2007-08-21 US US11/842,765 patent/US7473771B2/en not_active Expired - Fee Related
- 2007-10-25 US US11/924,488 patent/US7459300B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20070185010A1 (en) | 2007-08-09 |
US20070184461A1 (en) | 2007-08-09 |
CN1308677A (zh) | 2001-08-15 |
US20080097082A1 (en) | 2008-04-24 |
DE69935220D1 (de) | 2007-04-05 |
AU765349B2 (en) | 2003-09-18 |
US20080113428A1 (en) | 2008-05-15 |
US7655760B2 (en) | 2010-02-02 |
JP4424575B2 (ja) | 2010-03-03 |
AU4362499A (en) | 1999-12-06 |
EP1086225A2 (de) | 2001-03-28 |
US7473771B2 (en) | 2009-01-06 |
US20050014187A1 (en) | 2005-01-20 |
CA2329054A1 (en) | 1999-11-25 |
DE69935220T2 (de) | 2007-11-15 |
ES2281964T3 (es) | 2007-10-01 |
US7459300B2 (en) | 2008-12-02 |
US7271151B2 (en) | 2007-09-18 |
US6818745B1 (en) | 2004-11-16 |
EP1086225B1 (de) | 2007-02-21 |
DK1086225T3 (da) | 2007-05-21 |
TWI227734B (en) | 2005-02-11 |
CA2329054C (en) | 2011-03-08 |
WO1999060017A3 (en) | 2000-03-09 |
CN100359015C (zh) | 2008-01-02 |
MXPA00011272A (es) | 2003-04-22 |
WO1999060017A2 (en) | 1999-11-25 |
JP2002515232A (ja) | 2002-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE354656T1 (de) | Von menschlichem tumor stammendes polypeptidhormon phosphatonin | |
EP1082433A4 (de) | Interleukine 21 und 22 | |
WO2001058916A3 (en) | Antibodies to ccr5 | |
WO1998039446A3 (en) | 70 human secreted proteins | |
WO1998039448A3 (en) | 186 human secreted proteins | |
EP1053245A4 (de) | 45 menschliche sekretierte proteine | |
WO1998040483A3 (en) | 28 human secreted proteins | |
CY1111950T1 (el) | 32 ανθρωπινες εκκρινομενες πρωτεϊνες | |
WO1998045712A3 (en) | 20 human secreted proteins | |
DE69943022D1 (de) | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor | |
WO2000017222A8 (en) | 31 human secreted proteins | |
WO2000073323A3 (en) | Adam polynucleotides and polypeptides | |
WO2001008635A3 (en) | Calcium channel transport polynucleotides, polypeptides, and antibodies | |
EP1042342A4 (de) | 53 proteine menschlichen ursprungs | |
MY127669A (en) | Polypeptide hormone phosphatonin | |
UA72875C2 (uk) | БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ | |
WO2003083078A3 (en) | Novel human cell surface protein with immunoglobulin folds, bgs-19 | |
WO2004005487A3 (en) | Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 | |
WO2003031586A3 (en) | Acrp30-like polynucleotides, polypeptides, and antibodies | |
WO2000042165A3 (en) | Bone marrow-specific protein | |
MY126634A (en) | A novel polypeptide hormone phosphatonin | |
IL155687A0 (en) | Polynucleotides encoding hlrrsi1 polypeptides | |
WO2000071567A3 (en) | Fibroblast growth factor 13 | |
WO2002028873A8 (en) | Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon | |
EP1346999A3 (de) | Humane sekretierte Proteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1086225 Country of ref document: EP |